phenyl acetate has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagga, P; Chugani, AN; Patel, AB; Varadarajan, KS | 1 |
| Beal, MF; Browne, SE; Calingasan, NY; Gardian, G; Klivenyi, P; Saydoff, J; von Borstel, R; Yang, L | 1 |
2 other study(ies) available for phenyl acetate and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.
Topics: Acetates; Algorithms; Animals; Antiparkinson Agents; Blood Glucose; Brain Chemistry; Energy Metabolism; Glutamates; Hand Strength; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neostriatum; Oxidation-Reduction; Parkinson Disease, Secondary; Psychomotor Performance; Radiopharmaceuticals | 2013 |
Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Acetates; Animals; Dietary Supplements; Disease Models, Animal; Dopamine; Homovanillic Acid; Mice; MPTP Poisoning; Neuroprotective Agents; Neurotoxins; Uridine | 2004 |